Berkeley, CA · Founded 2016 · Privately Held (backing)
Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. Prellis Biologics is based in Berkeley, CA and was founded in 2016. It was valued at $110 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $70.2 million across 5 recorded rounds; the latest was a $17 million early-stage round in Jun 2022.
PMV mark · valuation
$110.1M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$70.2M
Last round
Early Stage VC
Jun 2022
Team — not yet on record
No current team members for Prellis Biologics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Prellis Biologics with a free account
·The complete investor list: 16 names
·Watch Prellis Biologics: the Monday email on marks, rounds and moves
